Oxaliplatin for colorectal cancer in the United States: better late than never.
Chau
Ian
I
Cunningham
David
D
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017277:Drug Approval; D005060:Europe; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007391:International Cooperation; D002955:Leucovorin / Q000008:administration & dosage; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D000077150:Oxaliplatin; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil